---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-026871"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2022-09-27T23:59:59+00:00"
generated_at: "2026-06-23T07:13:15.126154+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $71,500 convertible note to GS Capital

## Summary
- Principal $71,500 with $4,000 OID; net proceeds $67,500 for general working capital.
- Note bears 8% interest; convertible at $0.002/share (fixed) or $0.0009 if stock below $0.0014 for 5 days.
- Maturity March 21, 2023; prepayment premiums of 110%-130% depending on timing.
- Default conversion price at 65% of lowest trading price over 10 days; default interest 24% per annum.
- GS Capital paid $2,500 legal fees; conversion limited to 4.99% beneficial ownership.

## SEC filing metadata
- accession: 0001493152-22-026871
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2022-09-27T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315222026871/0001493152-22-026871-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315222026871/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-026871
- JSON: https://secwatch.observer/filing/0001493152-22-026871.json
- Plain text: https://secwatch.observer/filing/0001493152-22-026871.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.